May 6, 2026

Salk Institute welcomes Sarah Wolf Hallac to Board of Trustees

索尔克新闻


Salk Institute welcomes Sarah Wolf Hallac to Board of Trustees

LA JOLLA—Sarah Wolf Hallac has been appointed to the Salk Institute’s 理事会. She brings broad experience spanning technology, finance, and philanthropy and will help guide the Institute as it advances foundational science that fuels future breakthroughs.

Sarah Wolf Hallac joins the Salk Institute’s Board of Trustees.
Sarah Wolf Hallac joins the Salk Institute’s Board of Trustees.

Hallac is an advisor to VectoIQ and a director of VectoIQ acquisition corporation, a company that partners with startups and early-stage companies to develop next-generation smart transportation products and services, including autonomous vehicles, wireless vehicle charging, and fleet management solutions. She is also a consultant to BlackRock on significant philanthropic projects. Earlier in her career, Hallac was an investment banker at Bear, Stearns and Company, where she spent her tenure in the Financial Analytics and Structured Transaction Group.

“Sarah will bring thoughtful leadership to our Board at an important moment for science,” says Salk President Gerald Joyce, MD, PhD. “She understands that enduring discovery depends on strong institutions, and that makes her an exceptional addition to Salk.”

Hallac is a member of the Board of Advisors for Georgia Tech and the School of Engineering at the University of Pennsylvania. She also serves on the Board of Directors of Centro Primo Levi, a New York-based organization inspired by the humanistic legacy of writer and chemist Primo Levi.

Hallac earned a BSE in electrical engineering and a BS in economics from the University of Pennsylvania.

更多信息

宣传办公室
电话:(858) 453-4100
press@salk.edu

萨尔克生物学研究所

萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.